Ginsenoside Rh2-Liposome Potentiate Vaccine Immunity through Enhanced MHC‑I Presentation

Ginsenoside Rh2-Liposome Potentiate Vaccine Immunity through Enhanced MHC‑I Presentation

Saved in:

Bibliographic Details
Main Authors:	Qingqing Nie, Zhijie Chen, Wang Gong, Wenqiang Cao, Xue Wang, Yanna Liu, Shuai Zhang, Yuchen Yang, Ziyan Meng
Format:	Article
Language:	English
Published:	American Chemical Society 2025-07-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.5c03473
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nanoparticle conjugation of ginsenoside Rh2 enhanced antitumor efficacy on hepatocellular carcinoma
by: Fengkai Sun, et al.
Published: (2025-08-01)

Inhibitory Effect of Exosomes Loaded with Ginsenoside Rh2 on Growth of Hepatocellular Carcinoma Cells
by: Meile LI, et al.
Published: (2025-07-01)

Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism
by: Xue Bai, et al.
Published: (2025-06-01)

Ginsenoside Rh2 repressed the progression of prostate cancer through the mitochondrial damage induced by mitophagy and ferroptosis
by: Zhen He, et al.
Published: (2025-08-01)

Ginsenoside Rh2 inhibits breast cancer cell growth via<?A3B2 ACK?>ERβ-TNFα pathway
by: Peng Kunjian, et al.
Published: (2022-05-01)

Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I
by: Owen Leddy, et al.
Published: (2023-04-01)

Correction: Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I
by: Owen Leddy, et al.
Published: (2025-08-01)

Identification and Analysis of MHCⅡ Genes in Wuzhishan Pigs
by: LIU Yuanyuan, et al.
Published: (2025-06-01)

Antidepressant Effects of Ginsenosides from Panax notoginseng
by: Yang YAO, et al.
Published: (2012-03-01)

Anticancer Mechanisms of Ginsenoside Compound K: A Review
by: Yu-Po Lee, et al.
Published: (2025-05-01)

Pre-clinical evaluation of a divalent liposomal vaccine to control invasive candidiasis
by: Augusto Costa-Barbosa, et al.
Published: (2025-06-01)

Research Progress on the Structural Modification and Activity of Ginsenosides
by: Ruixiu XIE, et al.
Published: (2025-08-01)

Geometric deep learning improves generalizability of MHC-bound peptide predictions
by: Dario F. Marzella, et al.
Published: (2024-12-01)

Inhibition of ATM enhances the immunogenicity of triple-negative breast cancer by promoting MHC-I expression
by: Jiazhen Li, et al.
Published: (2025-08-01)

Inhibitory effect of Endostar on HIF-1 with upregulation of MHC-I in lung cancer cells
by: Ming-Zhen Zhao, et al.
Published: (2025-12-01)

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.
by: Alexandra J Spencer, et al.
Published: (2014-01-01)

Development and evaluation of an oral liposomal vaccine for the prevention of Edwardsiellosis in Anguilla japonica caused by Edwardsiella piscicida
by: Young Min Woo, et al.
Published: (2025-05-01)

CD4+ T Cells Promote IgG Production in MHC-Independent and ICAM-1-Dependent Manners in Pristane-Induced Lupus Mice
by: Shuai Liu, et al.
Published: (2022-01-01)

RhD alloimmunization – diagnostics, therapy and prophylaxis
by: Radoslaw Ciesielski, et al.
Published: (2024-11-01)

Decoding MHC loss: Molecular mechanisms and implications for immune resistance in cancer
by: Pei Lin, et al.
Published: (2025-07-01)

Role of MHC-Linked Susceptibility Genes in the Pathogenesis of Human and Murine Lupus
by: Manfred Relle, et al.
Published: (2012-01-01)

Ginsenoside 20(S)-Rg3 upregulates SQLE to reprogram cholesterol metabolism of ovarian cancer cells
by: Fang He, et al.
Published: (2025-08-01)

Ginsenoside Rb1 alleviates renal tubular epithelial cell injury in diabetic kidney disease by inhibiting the aldose reductase activity
by: Wang Meng-jing, et al.
Published: (2025-07-01)

Ginsenoside Rg1 controls CKLF1-mediated apoptosis to reduce hypoxic/reoxygenation injury in HT22 cells
by: Jinping Liang, et al.
Published: (2025-04-01)

Analysis of phytosterols encapsulated in pegylated liposomes
by: Joanna Igielska-Kalwat, et al.
Published: (2025-08-01)

PRODUCTION AND INVESTIGATION OF PROPERTIES OF LIPOSOMAL LEVOFLOXACIN
by: G. М. Sorokoumova, et al.
Published: (2013-10-01)

CARNOSINE-CONTAINING LIPOSOMES: PREPARATION AND PROPERTIES
by: N. A. Antonova, et al.
Published: (2016-12-01)

Ginsenoside Rb1 inhibits proliferation and promotes apoptosis by regulating HMGB1 in uterine fibroid cells
by: Jianqiang Zhang, et al.
Published: (2019-12-01)

Ginsenoside Rg1 as a Potential Regulator of Hematopoietic Stem/Progenitor Cells
by: Fang He, et al.
Published: (2021-01-01)

Harnessing Jasmonate Pathways: PgJAR1’s Impact on Ginsenoside Accumulation in Ginseng
by: Ru Zhang, et al.
Published: (2025-03-01)

Formation and Segregation of the Ru- and Rh-MgO Solid Solutions
by: Kazu Okumura, et al.
Published: (2024-11-01)

Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes.
by: Harini Ganeshan, et al.
Published: (2025-01-01)

Development of R8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer
by: Jing-Jing Liu, et al.
Published: (2019-12-01)

Liposome-encapsulated AICAR hydrogel regulates macrophage metabolic reprogramming via SIK1 activation to alleviate osteoarthritis
by: Yong Fu, et al.
Published: (2025-07-01)

The dominantly expressed class II molecule from a resistant MHC haplotype presents only a few Marek's disease virus peptides by using an unprecedented binding motif.
by: Samer Halabi, et al.
Published: (2021-04-01)

Comparative study on two kinds of brain-targeted liposomes co-modified by RVGP and R9 in different ways
by: Yu Hei, et al.
Published: (2025-12-01)

Co‐Expression of MHC‐II and ANXA1: Mediators of PD‐1/PD‐L1 Therapy Resistance in Breast Cancer
by: Hao Wang, et al.
Published: (2025-08-01)

Liposomal form of desferal as an effective chlamidial agent
by: N. V. Rukosueva, et al.
Published: (2012-12-01)

Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
by: Jenny H. Lee, et al.
Published: (2020-04-01)

NetTCR-struc, a structure driven approach for prediction of TCR-pMHC interactions
by: Sebastian N. Deleuran, et al.
Published: (2025-07-01)